{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:55:42Z","timestamp":1780552542539,"version":"3.54.1"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1546,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,11]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> The human immunodeficiency virus encodes three replication enzymes, which are required for a productive life\u2010cycle. Currently, several anti\u2010retroviral drugs are available for clinical use, and they are inhibitors of either the reverse transcriptase or the viral protease. The introduction of combination anti\u2010retroviral therapy (HAART) changed the prognosis of HIV infection. However, current therapy is not able to eradicate the virus, only suppress it; therefore, long\u2010term use of the drugs is required to keep the viral load under control. Most of the problems associated with the HIV therapy are the consequence of the necessarily long\u2010term use of the drugs. The long\u2010term effectiveness of current inhibitors as therapeutic agents is limited by the rapid development of drug\u2010resistant variants. Furthermore, various side effects have been reported. These side effects include hypersensitivity, mitochondrial toxicity, lypodystrophy syndrome, insulin resistance and cardiovascular disorders. Further drug development is necessary to design new compounds that have efficacy similar to the currently used drugs in the management of HIV infection and that are potent against the resistant viruses but do not exhibit unwanted metabolic side effects.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb03909.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T19:04:54Z","timestamp":1279652694000},"page":"145-159","source":"Crossref","is-referenced-by-count":35,"title":["HIV Inhibitors: Problems and Reality"],"prefix":"10.1111","volume":"946","author":[{"given":"J\u00d3ZSEF","family":"T\u00d6ZS\u00c9R","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.63.070194.001025"},{"key":"e_1_2_5_3_2","unstructured":"Vogt V.M. 1997. Retroviral virions and genomes.InRetroviruses. J.M. Coffin S.H. Hughes & H.E. Varmus Eds.: 27\u201369. Cold Spring Harbor Laboratory Press. Plainview NY."},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-75218-6_6"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02907811"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(90)91469-9"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biophys.27.1.249"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1654(200011\/12)10:6<385::AID-RMV296>3.0.CO;2-1"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2467383"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-5-951"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1654(200007\/08)10:4<231::AID-RMV290>3.0.CO;2-P"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(98)00025-4"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.71.2.1089-1096.1997"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.71.9.6662-6670.1997"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311906"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02854-3"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0595-417"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.13.2050"},{"key":"e_1_2_5_19_2","first-page":"552","article-title":"Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4\/3A5: mechanism\u2010based inactivation of cytochrome P450A3 by ritonavir","volume":"26","author":"Koudriakova T.","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1021\/js980082d"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03391-1"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.11.4274"},{"key":"e_1_2_5_23_2","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood.V96.10.3553","article-title":"HIV\u20101 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells","volume":"96","author":"Ikezoe T.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C000228200"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200002180-00001"},{"key":"e_1_2_5_26_2","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long\u2010term nucleoside analogue therapy","volume":"13","author":"Saint\u2010Marc T.","year":"1999","journal-title":"AIDS"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06102-4"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63513-1"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-10-199711150-00016"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-10-199711150-00017"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.4.1865"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.5.2593"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90968-9"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907223410404"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/377151a0"},{"key":"e_1_2_5_36_2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S0140-6736(98)26026-0","article-title":"Vascular complications associated with use of HIV protease inhibitors","volume":"351","author":"Behrens G.","year":"1998","journal-title":"Lancet"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79053-X"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-7-199910050-00032"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0796-753"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb03909.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb03909.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1749-6632.2001.tb03909.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb03909.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T09:29:04Z","timestamp":1694338144000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb03909.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb03909.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb03909.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}